chartexchange

NTLA
Intellia Therapeutics, Inc
stockNASDAQ

Market OpenNov 19, 2026 3:05:41 PM EST
9.12USD-6.602%(-0.64)4,695,981
Pre-marketNov 19, 2026 9:29:30 AM EST
9.91USD+1.433%(+0.14)
9.1200Bid9.1300Ask0.0100Spread
Loading…
Loading…
Healthcare
Biotechnology
CEO
John Leonard
HQ
Cambridge, MA, USA
Previous Close
$9.77
Beta
2.36
52-Week High
$18.48 2026-07-02
52-Week Low
$7.95 2025-11-21
SMA 50
$11.75
SMA 200
$12.91
Avg. Vol 10D
6.03M
Avg. Vol 30D
5.29M
Avg. Vol 90D
4.44M
Relative Vol
0.88
140.36M
134.16M
44,361,762
0.4100%
2,400,000
123
NTLA Profile

intellia therapeutic's core mission is to develop curative medicines, utilizing the promise of the crispr/cas9 gene editing technology. the development of crispr/cas9 gene editing technology opens a new frontier in biomedical research and clinical intervention. adapted from a natural cellular process, crispr/cas9 permits the editing of any gene in any organism with unprecedented simplicity and flexibility. the incredible potential of this technology for treating human genetic disease inspired a group of life science veterans to create intellia therapeutics. intellia was founded in 2014 by caribou biosciences and atlas venture, along with a consortium of scientists who have helped define the space. intellia therapeutics holds exclusive access to a broad intellectual property portfolio covering the application of crispr/cas9 technology for human therapeutic use. intellia has built an experienced team of individuals to meet the challenges of bringing crispr/cas9 therapeutics to the

NTLA Performance
PeriodPriceDateChangeBeta
1W10.552026-11-12-13.32%-3.548
1M11.582026-10-19-21.03%2.456
3M13.282026-08-19-31.14%2.290
6M11.942026-05-19-23.41%2.419
1Y8.242025-11-19+10.98%2.363
2Y14.132024-11-19-35.28%—
5Y129.482021-11-19-92.94%1.951
NTLA Stock Summary

Intellia Therapeutics, Inc (NASDAQ:NTLA) stock price today is $9.15, and today's volume is 4,671,514. NTLA is down 6.397% today. The 30 day average volume is 5.29M. NTLA market cap is $1.28B with 140.36M shares outstanding.